You need to sign in or sign up before continuing.
Archives of cardiovascular diseases
-
Arch Cardiovasc Dis · Oct 2015
Comparative StudyPlatelet effect of prasugrel and ticagrelor in patients with ST-segment elevation myocardial infarction.
Recent studies have suggested that ticagrelor 90mg twice daily provides stronger platelet inhibition than prasugrel 10mg once daily in acute coronary syndrome patients undergoing percutaneous coronary intervention. ⋯ The difference in platelet reactivity between ticagrelor and prasugrel varies according to the platelet function test in patients with STEMI. The differences observed may be related more to the tests than to the drugs used.